PATENT SECURITY AGREEMENT
Exhibit 10.37
Execution Version
This PATENT SECURITY AGREEMENT, dated as of 11 December, 2023 (this “Agreement”), is made by AVITA MEDICAL PTY LIMITED ACN 058 466 523 , an Australian proprietary company limited by shares (the “Grantor”), in favor of ORCO IV LLC, a Delaware limited liability company (together with its Affiliates, successors, transferees and assignees, the “Administrative Agent”), as Administrative Agent for the Secured Parties.
W I T N E S S E T H :
WHEREAS, pursuant to the Credit Agreement, dated as of October 18, 2023 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among AVITA Medical, Inc. (the “Borrower”), the Lenders party thereto and the Administrative Agent, the Lenders have extended Commitments to make Loans to the Borrower;
WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates have executed and delivered a Pledge and Security Agreement in favor of the Administrative Agent, for the benefit of the Secured Parties, dated as of October 18, 2023 (as amended, supplemented or otherwise modified from time to time, the “Security Agreement”);
WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of the Security Agreement, the Grantor is required to execute and deliver this Agreement and to grant to the Administrative Agent, for the benefit of the Secured Parties, a continuing security interest in all of the Patent Collateral to secure all of the Obligations; and
WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement;
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the benefit of the Secured Parties, as follows:
SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement.
SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Administrative Agent, for the benefit of the Secured Parties, a continuing security interest in all of the Grantor’s right, title and interest in and to the Patent Collateral, including each patent and patent application referred to in Item A of Schedule I attached hereto and each patent license referred to in Item B of Schedules 1 attached hereto. Notwithstanding anything to the contrary, the Patent Collateral does not include Excluded Property.
SECTION 3. Security Agreement. This Agreement has been executed and delivered by the Grantor for the purpose of registering the security interest of the Administrative Agent in the Patent Collateral with the United States Patent and Trademark Office. The security interest granted hereby has been granted in furtherance of, and not in limitation of, the security interest granted to the Administrative Agent for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Administrative Agent thereunder) shall remain in full force and effect in accordance with its terms.
SECTION 4. Release of Liens. Upon (a) the sale of Patent Collateral to Persons who are not the Borrower or any Subsidiary thereof in accordance with the Credit Agreement or (b) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (i) such Patent Collateral (in the case of clause (a)) or (ii) all Patent Collateral (in the case of clause (b)). Upon any such sale or termination, the Administrative Agent will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind whatsoever, all such Patent Collateral held by the Administrative Agent hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination.
SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Administrative Agent with respect to the security interest in the Patent Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein) are incorporated by reference herein as if fully set forth herein.
SECTION 6. Loan Document. This Agreement is a Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof.
SECTION 7. Effectiveness. (a) This Agreement shall become effective when a counterpart hereof executed by the Grantor shall have been received by the Administrative Agent.
(b) This document may be executed in any number of counterparts or copies, each of which may be executed by physical signature in wet ink or electronically (whether in whole or part). A party who has executed a counterpart of this document may exchange it with another party (the “Recipient”) by: (i) emailing a copy of the executed counterpart to the Recipient; or (ii) utilizing an electronic platform (including DocuSign) to circulate the executed counterpart, and will be taken to have adequately identified themselves by so emailing the copy to the Recipient or utilizing the electronic platform. (c) Each party consents to signatories and parties executing this document by electronic means and to identifying themselves in the manner specified in this clause. (d) Each counterpart constitutes an original (whether kept in electronic or paper form), all of which together constitute one instrument as if the signatures (or other execution markings) on the counterparts or copies were on a single physical copy of this document in paper form. Without limiting the foregoing, if any of the signatures or other markings on behalf of one party are on different counterparts or copies of this document, this shall be taken to be, and have the same effect as, signatures on the same counterpart and on a single copy of this document.
[Signature Page Follows]
2
IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and delivered by its Authorized Officer as of the date first above written.
Grantor
Executed as a deed by AVITA MEDICAL PTY LIMITED ACN 058 466 523 in accordance with Section 127 of the Corporations Act 2001 (Cth)
/s/ Xxx Xxxxxxxx |
|
/s/ Xxxxxxx Xxxx Xxxxx |
Signature of director |
|
Signature of director/company secretary |
|
|
|
Xxx Xxxxxxxx |
|
Xxxxxxx Xxxx Xxxxx |
Name of director (print) |
|
Name of director/company secretary (print)
|
[Signature Page to Patent Security Agreement]
SCHEDULE I
Item A. Patents
Title |
Pub. No. |
App. No. |
Filing Date |
Country |
Status |
Patent No. |
Issue Date |
Antici pated Expira tion |
Assignee |
CELL |
US2011 |
13/036, |
2/28/ |
United |
Granted |
9029140 |
5/12/ |
4/9/2 |
AVITA |
SUSPENSION |
015084 |
569 |
2011 |
States of |
|
|
2015 |
024 |
Medical |
PREPARATION |
8A1 |
|
|
America |
|
|
|
|
Pty Ltd1 |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
AU201 |
201320 |
3/14/ |
Australia |
Granted |
AU2013 |
11/2 |
3/14/ |
AVITA |
SUSPENSION |
320258 |
2587 |
2013 |
|
|
202587B |
6/20 |
2033 |
Medical |
AND USE |
7A1 |
|
|
|
|
2 |
15 |
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
MÉTODO |
BR1120 |
BR1120 |
3/14/ |
Brazil |
Granted |
BR11201 |
6/7/2 |
3/14/ |
AVITA |
PARA |
140232 |
140232 |
2013 |
|
|
4023272 |
022 |
2033 |
Medical |
PREPARAR |
72A2 |
725 |
|
|
|
B1 |
|
|
Pty Ltd |
CÉLULAS |
|
|
|
|
|
|
|
|
|
PARA USO |
|
|
|
|
|
|
|
|
|
COSMÉTICO |
|
|
|
|
|
|
|
|
|
EM UM |
|
|
|
|
|
|
|
|
|
PROCEDIMEN |
|
|
|
|
|
|
|
|
|
TO |
|
|
|
|
|
|
|
|
|
RELACIONAD |
|
|
|
|
|
|
|
|
|
O AO EPITÉLIO |
|
|
|
|
|
|
|
|
|
(METHOD FOR |
|
|
|
|
|
|
|
|
|
PREPARING |
|
|
|
|
|
|
|
|
|
CELLS FOR |
|
|
|
|
|
|
|
|
|
COSMETIC |
|
|
|
|
|
|
|
|
|
USE IN A |
|
|
|
|
|
|
|
|
|
PROCEDURE |
|
|
|
|
|
|
|
|
|
RELATED TO |
|
|
|
|
|
|
|
|
|
THE |
|
|
|
|
|
|
|
|
|
EPITHELIUM) |
|
|
|
|
|
|
|
|
|
Method for |
CA2874 |
CA2874 |
3/14/ |
Canada |
Granted |
CA2874 |
9/26/ |
3/14/ |
AVITA |
Preparing Cell |
091A1 |
000 |
0000 |
|
|
000 |
0000 |
0000 |
Medical |
Suspension |
|
|
|
|
|
|
|
|
Pty Ltd |
Comprising |
|
|
|
|
|
|
|
|
|
Undifferentiated/ |
|
|
|
|
|
|
|
|
|
Progenitor Cells |
|
|
|
|
|
|
|
|
|
and/or |
|
|
|
|
|
|
|
|
|
Differentiated |
|
|
|
|
|
|
|
|
|
Cells |
|
|
|
|
|
|
|
|
|
1 Assignee identified as AVITA Medical Pty Ltd in this schedule refers either to AVITA Medical Pty Ltd or AVITA Medical Ltd. On October 1, 2020, AVITA Medical Ltd converted to a proprietary company and changed its name to AVITA Medical PTY Limited.
细胞悬液及其 |
CN1046 |
CN2013 |
3/14/ |
China |
Pending |
|
|
3/14/ |
AVITA |
用途 (CELL SUSPENSIONS |
85049A |
800247 37 |
2013 |
|
|
2033 |
Medical Pty Ltd |
||
AND THEIR |
|
|
|
|
|
|
|
||
USES) |
|
|
|
|
|
|
|
||
CELL |
EP2828 |
EP2013 |
3/14/ |
Germany |
Granted |
EP28283 |
2/17/ |
3/14/ |
AVITA |
SUSPENSION |
378A1 |
764726 |
2013 |
|
|
78B1 |
2021 |
2033 |
Medical |
AND USE |
|
|
|
|
|
|
|
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
CELL |
ES2864 |
EP2013 |
3/14/ |
Spain |
Granted |
ES28647 |
2/17/ |
3/14/ |
AVITA |
SUSPENSION |
772T3 |
764726 |
2013 |
|
|
72T3 |
2021 |
2033 |
Medical |
AND USE |
|
|
|
|
|
|
|
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
CELL |
EP2828 |
EP2013 |
3/14/ |
France |
Granted |
EP28283 |
2/17/ |
3/14/ |
AVITA |
SUSPENSION |
378A1 |
764726 |
2013 |
|
|
78B1 |
2021 |
2033 |
Medical |
AND USE |
|
|
|
|
|
|
|
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
CELL |
EP2828 |
EP2013 |
3/14/ |
United |
Granted |
EP28283 |
2/17/ |
3/14/ |
AVITA |
SUSPENSION |
378A1 |
764726 |
2013 |
Kingdom |
|
78B1 |
2021 |
2033 |
Medical |
AND USE |
|
|
|
|
|
|
|
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
細胞懸液及其 用途 (CELL SUSPENSIONS AND THEIR USES) |
HK120 7662A |
HK151 08195 |
3/14/ 2013 |
Hong Kong |
Pending |
|
|
3/14/ 2033 |
AVITA Medical Pty Ltd |
CELL |
EP2828 |
EP2013 |
3/14/ |
Italy |
Granted |
EP28283 |
2/17/ |
3/14/ |
AVITA |
SUSPENSION |
378A1 |
764726 |
2013 |
|
|
78B1 |
2021 |
2033 |
Medical |
AND USE |
|
|
|
|
|
|
|
|
Pty Ltd |
THEREOF |
|
|
|
|
|
|
|
|
|
CELL |
EP3896 |
EP2021 |
3/14/ |
European |
Pending |
|
|
3/14/ |
AVITA |
SUSPENSION |
152A1 |
156318 |
2013 |
Patent |
|
2033 |
Medical |
||
AND USE |
|
|
|
Office |
|
|
Pty Ltd |
||
THEREOF |
|
|
|
|
|
|
|
||
CELL |
US2020 |
16/592, |
10/3/ |
United |
Pending |
|
|
3/14/ |
AVITA |
SUSPENSION |
009395 |
108 |
2019 |
States of |
|
2033 |
Medical |
||
AND USE |
1A1 |
|
|
America |
|
|
Pty Ltd |
||
THEREOF |
|
|
|
|
|
|
|
||
CELL |
US2020 |
16/592, |
10/3/ |
United |
Pending |
|
|
3/14/ |
AVITA |
SUSPENSION |
009395 |
117 |
2019 |
States of |
|
2033 |
Medical |
||
AND USE |
2A1 |
|
|
America |
|
|
Pty Ltd |
||
THEREOF |
|
|
|
|
|
|
|
||
SYSTEMS AND |
AU201 |
201320 |
4/13/ |
Australia |
Granted |
AU2013 |
2/12/ |
4/13/ |
AVITA |
METHODS FOR |
320514 |
5148 |
2013 |
|
|
205148B |
2015 |
2033 |
Medical |
TISSUE |
8A1 |
|
|
|
|
2 |
|
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM |
CA2906 088A1 |
CA2906 088 |
3/14/ 2014 |
Canada |
Pending |
|
|
3/14/ 2034 |
AVITA Medical Pty Ltd |
用于组织处理以及由其制备 细胞悬液的系 |
CN1051 89729A |
CN2014 800256 99.5 |
3/14/ 2014 |
China |
Granted |
CN1051 89729B |
1/10/ 2020 |
3/14/ 2034 |
AVITA Medical Pty Ltd |
统和方法 |
|
|
|
|
|
|
|
|
|
(SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSIONs THEREFROM) |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
EP2970 |
EP2014 |
3/14/ |
Germany |
Granted |
EP29708 |
11/1 |
3/14/ |
AVITA |
METHODS FOR |
856A1 |
770177 |
2014 |
|
|
56B1 |
3/20 |
2034 |
Medical |
TISSUE |
|
|
|
|
|
|
19 |
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
ES2759 |
ES2014 |
3/14/ |
Spain |
Granted |
ES27590 |
11/1 |
3/14/ |
AVITA |
METHODS FOR |
063T3 |
770177 |
2014 |
|
|
63T3 |
3/20 |
2034 |
Medical |
TISSUE |
|
T |
|
|
|
|
19 |
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
EP2970 |
EP2014 |
3/14/ |
France |
Granted |
EP29708 |
11/1 |
3/14/ |
AVITA |
METHODS FOR |
856A1 |
770177 |
2014 |
|
|
56B1 |
3/20 |
2034 |
Medical |
TISSUE |
|
|
|
|
|
|
19 |
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM |
EP2970 856A1 |
EP2014 770177 |
3/14/ 2014 |
United Kingdom |
Granted |
EP29708 56B1 |
11/1 3/20 19 |
3/14/ 2034 |
AVITA Medical Pty Ltd |
用於組織處理以及由其製備 細胞懸液的系 |
HK121 9291A |
HK161 07310 |
6/23/ 2016 |
Hong Kong |
Granted |
HK1219 291 |
1/29/ 2021 |
3/14/ 2034 |
AVITA Medical Pty Ltd |
統和方法 |
|
|
|
|
|
|
|
|
|
(SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM) |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
EP2970 |
EP2014 |
3/14/ |
Italy |
Granted |
EP29708 |
11/1 |
3/14/ |
AVITA |
METHODS FOR |
856A1 |
770177 |
2014 |
|
|
56B1 |
3/20 |
2034 |
Medical |
TISSUE |
|
|
|
|
|
|
19 |
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
JP2016 |
JP2016- |
3/14/ |
Japan |
Granted |
JP64797 |
2/15/ |
3/14/ |
AVITA |
METHODS FOR |
512689 |
502942 |
2014 |
|
|
57B2 |
2019 |
2034 |
Medical |
TISSUE |
A |
|
|
|
|
|
|
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
US2016 |
14/776, |
3/14/ |
United |
Granted |
US10626 |
4/21/ |
3/14/ |
AVITA |
METHODS FOR |
002445 |
038 |
2014 |
States of |
|
358B2 |
2020 |
2034 |
Medical |
TISSUE |
0A1 |
|
|
America |
|
|
|
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM |
CN1113 04081A |
CN2019 113434 17.7 |
3/14/ 2014 |
China |
Pending |
|
|
3/14/ 2034 |
AVITA Medical Pty Ltd |
SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM |
EP3674 396A1 |
EP2019 208169 |
3/14/ 2014 |
European Patent Office |
Pending |
|
|
3/14/ 2034 |
AVITA Medical Pty Ltd |
SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM |
HK400 32292A |
HK420 200219 09 |
6/23/ 2016 |
Hong Kong |
Pending |
|
|
3/14/ 2034 |
AVITA Medical Pty Ltd |
SYSTEMS AND |
US2020 |
16/787, |
2/11/ |
United |
Granted |
US11124 |
9/21/ |
3/14/ |
AVITA |
METHODS FOR |
020808 |
882 |
2020 |
States of |
|
752B2 |
2021 |
2034 |
Medical |
TISSUE |
6A1 |
|
|
America |
|
|
|
|
Pty Ltd |
PROCESSING |
|
|
|
|
|
|
|
|
|
AND |
|
|
|
|
|
|
|
|
|
PREPARATION |
|
|
|
|
|
|
|
|
|
OF CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
THEREFROM |
|
|
|
|
|
|
|
|
|
SYSTEMS AND |
|
18/370, |
9/20/ |
United |
Pending |
|
|
3/14/ |
AVITA |
METHODS FOR |
842 |
2023 |
States of |
Reissue |
2034 |
Medical |
|||
TISSUE |
|
|
America |
Application |
|
Pty Ltd |
|||
PROCESSING |
|
|
|
|
|
|
|||
AND |
|
|
|
|
|
|
|||
PREPARATION |
|
|
|
|
|
|
|||
OF CELL |
|
|
|
|
|
|
|||
SUSPENSION |
|
|
|
|
|
|
|||
THEREFROM |
|
|
|
|
|
|
|||
CELL |
AT5105 |
AT2002 |
2/7/2 |
Austria |
Expired |
AT51054 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
48T |
709917 |
002 |
|
|
8T |
5/20 |
022 |
Medical |
PREPARATION |
|
T |
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
AU200 |
AU200 |
2/7/2 |
Australia |
Expired |
AU2002 |
03/0 |
2/7/2 |
AVITA |
SUSPENSION |
222780 |
222780 |
002 |
|
|
227802B |
5/20 |
022 |
Medical |
PREPARATION |
2A1 |
2 |
|
|
|
2 |
07 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
BRPI0 |
BRPI02 |
2/7/2 |
Brazil |
Expired |
BRPI020 |
06/1 |
2/7/2 |
AVITA |
SUSPENSION |
206692 |
06692 |
002 |
|
|
6692B1 |
9/20 |
022 |
Medical |
PREPARATION |
A2 |
|
|
|
|
|
18 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
DE6024 |
DE6024 |
2/7/2 |
Germany |
Expired |
DE60240 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
0127T2 |
0127 |
002 |
|
|
127T2 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
135792 |
2/7/2 |
Spain |
Expired |
1357922 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
2 |
002 |
|
|
|
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
027099 |
02/07 |
Belgium |
Expired |
1357922 |
05/2 |
02/07 |
AVITA |
SUSPENSION |
2 |
175 |
/2002 |
|
|
|
5/20 |
/2022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
France |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
|
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
United |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
Kingdom |
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
HK105 |
410062 |
2/7/2 |
Hong |
Expired |
HK1057 |
4081 |
2/7/2 |
AVITA |
SUSPENSION |
7713 |
8.6 |
002 |
Kong |
|
713 |
6 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
|
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
Italy |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
|
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
2004- |
2002- |
2/7/2 |
Japan |
Expired |
JP52140 |
4134 |
2/7/2 |
AVITA |
SUSPENSION |
529872 |
562365 |
002 |
|
|
85 |
1 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
|
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
Netherlands |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
|
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
PT1357 |
EP2002 |
2/7/2 |
Portugal |
Expired |
EP13579 |
09/0 |
2/7/2 |
AVITA |
SUSPENSION |
922E |
709917 |
002 |
|
|
22 |
1/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
Sweden |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
|
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
135792 |
EP2002 |
2/7/2 |
Turkey |
Expired |
EP13579 |
05/2 |
2/7/2 |
AVITA |
SUSPENSION |
2 |
709917 |
002 |
|
|
22 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
11 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND USE |
|
|
|
|
|
|
|
|
|
CELL |
AT717 |
AT2010 |
2/7/2 |
Austria |
Expired |
AT71788 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
889T |
184235 |
002 |
|
|
9 |
5/20 |
022 |
Medical |
PREPARATION |
|
T |
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
101842 |
2/7/2 |
Belgium |
Expired |
EP23430 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
35.9 |
002 |
|
|
79 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL SUSPENSION PREPARATION DEVICE |
DE602 47071 |
602470 71-4 |
2/7/2 002 |
Germany |
Expired |
DE60247 071T2 |
03/2 5/20 15 |
2/7/2 022 |
AVITA Medical Pty. Ltd. |
CELL SUSPENSION PREPARATION DEVICE |
234307 9 |
101842 35.9 |
2/7/2 002 |
Spain |
Expired |
EP23430 79 |
03/2 5/20 15 |
2/7/2 022 |
AVITA Medical Pty. Ltd. |
CELL SUSPENSION PREPARATION DEVICE |
234307 9 |
101842 35.9 |
2/7/2 002 |
France |
Expired |
EP23430 79 |
03/2 5/20 15 |
2/7/2 022 |
AVITA Medical Pty. Ltd. |
CELL SUSPENSION PREPARATION DEVICE |
234307 9 |
101842 35.9 |
2/7/2 002 |
United Kingdom |
Expired |
EP23430 79 |
03/2 5/20 15 |
2/7/2 022 |
AVITA Medical Pty. Ltd. |
CELL |
502015 |
101842 |
2/7/2 |
Italy |
Expired |
EP23430 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
000011 |
35.9 |
002 |
|
|
79 |
5/20 |
022 |
Medical |
PREPARATION |
254 |
|
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
101842 |
2/7/2 |
Netherlands |
Expired |
EP23430 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
35.9 |
002 |
|
|
79 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
PT1357 |
PT2002 |
2/7/2 |
Portugal |
Expired |
PT13579 |
09/0 |
2/7/2 |
AVITA |
SUSPENSION |
922E |
709917 |
002 |
|
|
22E |
1/20 |
022 |
Medical |
PREPARATION |
|
T |
|
|
|
|
11 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
101842 |
2/7/2 |
Sweden |
Expired |
EP23430 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
35.9 |
002 |
|
|
79 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
101842 |
2/7/2 |
Turkey |
Expired |
EP23430 |
03/2 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
35.9 |
002 |
|
|
79 |
5/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
15 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
DE602 |
DE6024 |
2/7/2 |
Germany |
Expired |
DE60249 |
08/0 |
2/7/2 |
AVITA |
SUSPENSION |
49971T |
9971 |
002 |
|
|
971T2 |
7/20 |
022 |
Medical |
PREPARATION |
2 |
|
|
|
|
|
19 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
151598 |
2/7/2 |
Spain |
Expired |
EP29572 |
08/0 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
90.1 |
002 |
|
|
88 |
7/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
19 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
151598 |
2/7/2 |
France |
Expired |
EP29572 |
08/0 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
90.1 |
002 |
|
|
88 |
7/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
19 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
151598 |
2/7/2 |
United |
Expired |
EP29572 |
08/0 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
90.1 |
002 |
Kingdom |
|
88 |
7/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
19 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
HK121 |
HK161 |
2/7/2 |
Hong |
Expired |
HK1610 |
08/2 |
2/7/2 |
AVITA |
SUSPENSION |
2885A1 |
00778 |
002 |
Kong |
|
0778 |
1/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
20 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
234307 |
151598 |
2/7/2 |
Italy |
Expired |
EP29572 |
08/0 |
2/7/2 |
AVITA |
SUSPENSION |
9 |
90.1 |
002 |
|
|
88 |
7/20 |
022 |
Medical |
PREPARATION |
|
|
|
|
|
|
19 |
|
Pty. Ltd. |
DEVICE |
|
|
|
|
|
|
|
|
|
METHOD FOR |
JP2014 |
JP2014 |
2/7/2 |
Japan |
Expired |
JP60423 |
11/1 |
2/7/2 |
AVITA |
PREPARING |
193415 |
134495 |
002 |
|
|
77 |
8/20 |
022 |
Medical |
CELL |
A |
|
|
|
|
|
16 |
|
Pty. Ltd. |
SUSPENSION, |
|
|
|
|
|
|
|
|
|
AND CELL |
|
|
|
|
|
|
|
|
|
SUSPENSION |
|
|
|
|
|
|
|
|
|
CELL |
US2011 |
13/223, |
9/1/2 |
United |
Expired |
9078741 |
07/1 |
2/7/2 |
AVITA |
SUSPENSION |
031149 |
577 |
011 |
States of |
|
|
4/20 |
022 |
Medical |
PREPARATION |
7A1 |
|
|
America |
|
|
15 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
US2015 |
14/645, |
3/12/ |
United |
Expired |
9867692 |
01/1 |
2/7/2 |
AVITA |
SUSPENSION |
018273 |
933 |
2015 |
States of |
|
|
6/20 |
022 |
Medical |
PREPARATION |
9A1 |
|
|
America |
|
|
18 |
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
US201 |
15/838, |
12/12 |
United |
Expired |
1072953 |
8/4/2 |
2/7/2 |
AVITA |
SUSPENSION |
800988 |
429 |
/2017 |
States of |
|
6 |
020 |
022 |
Medical |
PREPARATION |
40A1 |
|
|
America |
|
|
|
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
CELL |
US2019 |
16/436, |
6/10/ |
United |
Expired |
1072953 |
4/28/ |
2/7/2 |
AVITA |
SUSPENSION |
030755 |
693 |
2019 |
States of |
|
6 |
2020 |
022 |
Medical |
PREPARATION |
0A1 |
|
|
America |
|
|
|
|
Pty. Ltd. |
TECHNIQUE |
|
|
|
|
|
|
|
|
|
AND DEVICE |
|
|
|
|
|
|
|
|
|
METHOD FOR |
JP2010 |
JP2010- |
2/7/2 |
Japan |
Withdrawn |
|
|
|
AVITA |
PREPARING |
269159 |
163176 |
002 |
|
|
Medical |
|||
CELL |
A |
|
|
|
|
Pty. Ltd. |
|||
SUSPENSION, |
|
|
|
|
|
|
|||
AND CELL |
|
|
|
|
|
|
|||
SUSPENSION |
|
|
|
|
|
|
|||
CELL |
US200 |
10/068, |
2/6/2 |
United |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
201063 |
299 |
002 |
States of |
|
Medical |
|||
PREPARATION |
53A1 |
|
|
America |
|
Pty. Ltd. |
|||
TECHNIQUE |
|
|
|
|
|
|
|||
AND DEVICE |
|
|
|
|
|
|
|||
CELL |
US201 |
12/699, |
2/3/2 |
United |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
001963 |
554 |
010 |
States of |
|
Medical |
|||
PREPARATION |
34A1 |
|
|
America |
|
Pty. Ltd. |
|||
TECHNIQUE |
|
|
|
|
|
|
|||
AND DEVICE |
|
|
|
|
|
|
|||
CELL |
EP3632 |
EP2019 |
2/7/2 |
European |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
452A1 |
190195 |
002 |
Patent |
|
Medical |
|||
PREPARATION |
|
|
|
Office |
|
Pty. Ltd. |
|||
DEVICE |
|
|
|
|
|
|
CELL |
HK400 |
HK420 |
2/7/2 |
Hong |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
18126A |
200074 |
002 |
Kong |
|
Medical |
|||
PREPARATION |
|
98 |
|
|
|
Pty. Ltd. |
|||
TECHNIQUE |
|
|
|
|
|
|
|||
AND USE |
|
|
|
|
|
|
|||
CELL |
US2021 |
16/935, |
7/21/ |
United |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
016963 |
015 |
2020 |
States of |
|
Medical |
|||
PREPARATION |
6A1 |
|
|
America |
|
Pty. Ltd. |
|||
TECHNIQUE |
|
|
|
|
|
|
|||
AND DEVICE |
|
|
|
|
|
|
|||
CELL |
US2015 |
14/386, |
3/14/ |
United |
Abandoned |
|
|
|
AVITA |
SUSPENSION |
007915 |
519 |
2013 |
States of |
|
Medical |
|||
AND USE |
3A1 |
|
|
America |
|
Ltd. |
|||
THEREOF |
|
|
|
|
|
|
|||
SYSTEMS AND |
N/A |
17/462, |
8/31/ |
United |
Abandoned |
|
|
|
AVITA |
METHODS FOR |
|
694 |
2021 |
States of |
|
Medical |
|||
TISSUE |
|
|
|
America |
|
Ltd. |
|||
PROCESSING |
|
|
|
|
|
|
|||
AND |
|
|
|
|
|
|
|||
PREPARATION |
|
|
|
|
|
|
|||
OF CELL |
|
|
|
|
|
|
|||
SUSPENSION |
|
|
|
|
|
|
|||
THEREFROM |
|
|
|
|
|
|
Item B. Patent Licenses None
